VistaGen Therapeutics(VTGN) - 2022 Q1 - Earnings Call Transcript

VistaGen Therapeutics, Inc. (NASDAQ:VTGN) Q1 2022 Earnings Conference Call August 12, 2021 5:00 PM ET Company Participants Mark Flather - Vice President, Investor Relations Shawn Singh - Chief Executive Officer Jerry Dotson - Chief Financial Officer Mark Smith - Chief Medical Officer Conference Call Participants Andrew Tsai - Jefferies Operator Greetings, and welcome to the VistaGen Therapeutics First Quarter 2022 Results Conference Call. During the presentation, all participants will be in a listen-only m ...